BioSpace News Archive

Biotech Beach

Patient-Derived Tumor Organoid Drug Development Platform LaunchedIndustry Leading Innovation Promises to Disrupt Traditional Drug Discovery

Crown Bioscience today announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the predictivity and speed of preclinical drug discovery.

October 17, 2019
·
3 min read
Pharm Country

AMC Health Unveils Their 360-degree Patient View, Including New Website, Social and Digital Health Care Engagement

AMC Health, a leader in virtual healthcare delivery solutions, is pleased to announce the launch of its newly redesigned website at https://www.amchealth.com.

October 17, 2019
·
4 min read
Drug Development

Amygdala Neurosciences Announces Dosing of the First Patient in the NIH Funded Phase 2 Proof-Of-Concept study of ANS-6637 for the Treatment of Alcohol Use Disorder

ANS-6637 is a new chemical entity selective ALDH2 Inhibitor with a mechanism of action expected to prevent craving and relapse for patients being treated for substance use disorders including alcohol use disorder.

October 17, 2019
·
3 min read
Job Trends

StemSpine® to Launch in the United States Following Successful Treatments Overseas with 12+ Months Data Showing Safety and Efficacy

Creative Medical Technology Holdings, Inc., a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, announced the successful clinical commercialization of StemSpine®.

October 17, 2019
·
2 min read
Policy

ASP Framework Points the Way Forward For Building National, Multi-Disciplinary Key Stakeholder Collaboration In Precision Medicine

American Society of Pharmacovigilance directors presented to key stakeholders in the field of pharmacogenomics, a detailed framework for building a national, public-private multi-disciplinary stakeholder collaboration to accelerate the development of precision medicine practices as a standard of care.

October 17, 2019
·
1 min read
Business

Teijin and NeuroSigma Enter into Exclusive License Agreement

Teijin Pharma to Market eTNS for the Treatment of ADHD in JaAs part of the agreement, Teijin Pharma will seek regulatory approval in Japan for the Monarch eTNS System (Monarch) for the treatment of ADHD.pan

October 17, 2019
·
4 min read
Business

DionyMed Receives Notice of Default and Demand for Payment and Notice of Intention to Enforce Security

GLAS America will not have the right to enforce its security over the Company and its assets until the expiry of the 10-day period after the BIA Notice was sent unless the Company consents to an earlier enforcement.

October 17, 2019
·
2 min read
Business

Solos Endoscopy, Inc. Appoints Distributor to Expand Their MammoView Sales Into India

This is a follow up to the successful introduction, by Shreyaas Healthcare, of Solos’ MammoView ductoscopy products at the 8th Annual Conference of Association of Breast Surgeons of India

October 17, 2019
·
2 min read
Business

Rafael Pharmaceuticals Enters into Collaboration with the National Institutes of Health (NIH) to Test CPI-613® (devimistat) in Cytokine Independent (Acute) HTLV-1 Associated Adult T-cell Leukemia/Lymphoma

Rafael will provide the compound for the study.

October 17, 2019
·
4 min read
Biotech Beach

INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting

Data on Neuroinflammation and Alzheimer’s Disease to be Presented by Dr. Malú Tansey; Presentation Selected for Meeting’s Press Conference

October 17, 2019
·
5 min read